Page last updated: 2024-10-23

azathioprine and Myeloproliferative Disorders

azathioprine has been researched along with Myeloproliferative Disorders in 4 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.

Research Excerpts

ExcerptRelevanceReference
"No significant risk for other intestinal cancers was found, especially for small bowel carcinoma."1.43Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study. ( Charpentier, C; Cheddani, H; Dauchet, L; Dupas, JL; Fumery, M; Gower-Rousseau, C; Marie Bouvier, A; Pariente, B; Peyrin-Biroulet, L; Savoye, G, 2016)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheddani, H1
Dauchet, L1
Fumery, M1
Charpentier, C1
Marie Bouvier, A1
Dupas, JL1
Pariente, B1
Peyrin-Biroulet, L1
Savoye, G1
Gower-Rousseau, C1
Burki, TK1
Tavadia, SM1
Mydlarski, PR1
Reis, MD1
Mittmann, N1
Pinkerton, PH1
Shear, N1
Sauder, DN1
Mey, U1
Franke, A1
Fuchs, R1

Other Studies

4 other studies available for azathioprine and Myeloproliferative Disorders

ArticleYear
Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    The American journal of gastroenterology, 2016, Volume: 111, Issue:10

    Topics: Adrenal Cortex Hormones; Age of Onset; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroi

2016
Azathioprine associated with myeloid neoplasm risk.
    The Lancet. Oncology, 2017, Volume: 18, Issue:3

    Topics: Autoimmune Diseases; Azathioprine; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Myelo

2017
Screening for azathioprine toxicity: a pharmacoeconomic analysis based on a target case.
    Journal of the American Academy of Dermatology, 2000, Volume: 42, Issue:4

    Topics: Adult; Azathioprine; Costs and Cost Analysis; Female; Genetic Testing; Homozygote; Humans; Immunosup

2000
[Acute mature myelocytic leukemia as a form of the myeloproliferative syndrome].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1979, Sep-15, Volume: 34, Issue:18

    Topics: Acute Disease; Adult; Azathioprine; Bone Marrow Examination; Fetal Hemoglobin; Hematopoietic Stem Ce

1979